Gintės ortodontija - Company finances
|
EUR
|
2022
From: 2022-11-03
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|
|
Financial data
|
||||
| Sales revenue | - | 30,013 | 41,568 | 38,027 |
| Profit before tax | -1 | 9,609 | 13,552 | 3,077 |
| Net profit | -1 | 9,129 | 12,874 | 2,892 |
| Equity | 99 | 9,228 | 22,102 | 24,994 |
| Liabilities | 205 | 685 | 883 | 390 |
| Non-current assets | 0 | 0 | 0 | 0 |
| Current assets | 304 | 9,913 | 22,985 | 25,384 |
| Total assets | 304 | 9,913 | 22,985 | 25,384 |
|
Taxes paid
|
||||
| STI taxes | - | 287 | 480 | 678 |
|
Financial indicators
|
||||
| Revenue change y/y | - | - | +38.5% | -8.5% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | -0.3% | 92.1% | 56.0% | 11.4% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | -1.0% | 98.9% | 58.2% | 11.6% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | - | 30.4% | 31.0% | 7.6% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | - | 32.0% | 32.6% | 8.1% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 2.1 | 0.1 | 0.0 | 0.0 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | - | - | - | - |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Gintės ortodontija - Social security debts
The company had no debts to Sodra
Gintės ortodontija - VMI tax arrears
The company had no tax arrears (debts) to the State Tax Inspectorate
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Gintes ortodontija, MB (company code 306171235) is a Lithuanian small partnership engaged in the manufacture of other medical and dental devices, instruments and supplies. In 2025, the company generated revenue of €38.0K, down 8.5% year on year from €41.6K in 2024, but still above the €30.0K recorded in 2023. Over the two-year period, revenue increased by 26.7% compared with 2023, showing overall growth despite the latest decline. Net profit fell to €2.9K in 2025 from €12.9K in 2024 and €9.1K in 2023, and the profit margin weakened to 7.6% from 31.0% in 2024 and 30.4% in 2023. At the same time, the balance sheet remained solid, with total assets of €25.4K, equity of €25.0K and liabilities of only €390. The equity ratio stood at 98.5%, debt-to-equity at 0.02, and asset turnover at 1.50x. Return on equity was 11.6% and return on assets 11.4% in 2025.